Evaluation of QTc Interval Prolongation in Breast Cancer Patients after Treatment with Epirubicin, Cyclophosphamide, and Docetaxel and the Influence of Interobserver Variation

Publisher: Karger

E-ISSN: 1661-3805|12|1|40-44

ISSN: 1661-3791

Source: Breast Care, Vol.12, Iss.1, 2017-01, pp. : 40-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract